Semaglutide and Skin Changes: Addressing 'Ozempic Face' and Other Effects

Written by Adam Maggio | Medically reviewed by Dr. James Whitfield, DO, FACOI

Semaglutide-induced weight loss can lead to 'Ozempic face' due to rapid fat loss, causing gauntness and loose skin. While injection site reactions are usually mild, GLP-1s may also offer anti-inflammatory benefits for skin. Proactive skincare, nutrition, and cosmetic interventions can help manage aesthetic concerns.

Patients embarking on a weight loss journey with semaglutide often notice significant changes in their skin, some expected and others less so. While the primary goal of semaglutide is metabolic improvement and weight reduction, its profound effects on body composition can manifest visibly on the skin, leading to both aesthetic concerns and occasional dermatological reactions.

One of the most commonly discussed phenomena is "Ozempic face," a term coined to describe the gaunt, sunken appearance that can result from rapid fat loss in the face. Cleveland Clinic (2025) characterizes it by "gauntness, sunken cheeks, new wrinkles and loose skin on the face and neck." This is not a direct side effect of semaglutide itself, but rather a consequence of losing subcutaneous fat, which provides structural support and volume to the face. As fat diminishes, the skin, particularly in older individuals or those with less elasticity, may not retract sufficiently, leading to a more aged or deflated look. Dr. Keusch (2025) also notes that plastic surgeons have observed significant issues with skin quality in patients experiencing rapid weight loss with semaglutide. Unlike a direct drug-induced skin condition, "Ozempic face" is a visible manifestation of successful, albeit rapid, weight reduction.

Beyond aesthetic changes, some patients may experience localized skin reactions at the injection site. These are typically mild and transient, including redness, itching, swelling, or a small lump (GoodRx, 2025). These reactions are generally manageable and often resolve on their own. More rarely, semaglutide has been linked to unusual skin sensations, such as burning, as documented in a case report by Barnett et al. (2025). While these are less common, patients should report any persistent or severe injection site reactions to their healthcare provider.

Interestingly, GLP-1 receptor agonists like semaglutide may also have more direct, beneficial dermatological implications. Research suggests that GLP-1RAs exert anti-inflammatory and immunomodulatory effects (Narla et al., 2026). This has spurred investigations into their potential role in inflammatory skin diseases. Patino et al. (2025) and USDermatology Partners (2026) highlight promising anti-inflammatory effects and improvements in conditions like psoriasis and hidradenitis suppurativa. This suggests a dual nature: while rapid weight loss can present aesthetic challenges, the underlying pharmacological action of semaglutide might offer systemic benefits for skin health, particularly in inflammatory contexts. Unlike the visible sagging, these anti-inflammatory effects are often subtle but contribute to overall skin well-being.

To mitigate the aesthetic concerns associated with rapid facial fat loss, several strategies can be employed. Maintaining adequate hydration is fundamental for skin elasticity. Ensuring a diet rich in protein and essential fatty acids supports skin health and collagen production. For those experiencing significant skin laxity, non-invasive cosmetic procedures like radiofrequency or ultrasound treatments can help tighten skin, while dermal fillers can restore lost volume in the face. Surgical options, such as facelifts, are also available for more pronounced sagging (Norcal Surgery, 2025). These interventions can help align the external appearance with the internal health improvements achieved through weight loss.

It"s also important to manage expectations. Rapid weight loss, while medically beneficial, often comes with visible changes. Patients should discuss these potential skin changes with their healthcare provider or a dermatologist before or during treatment. Unlike ignoring these concerns, proactive planning allows for a more holistic approach to the weight loss journey, addressing both health and aesthetic outcomes. Regular skin care, including moisturizing and sun protection, remains crucial for maintaining overall skin health.

For patients on semaglutide, understanding that skin changes, particularly facial volume loss, are often a consequence of successful weight reduction rather than a direct drug side effect is key. While injection site reactions are usually mild, the broader impact on skin health can be managed with proactive skincare, nutritional support, and, if desired, cosmetic interventions. Discuss any skin concerns with your doctor to ensure a comprehensive approach to your health and appearance during your weight loss journey.